Company or ticker...

Editas Medicine

Editas develops gene-editing medicines using CRISPR technology.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

EDIT

478.2M

9.7

n/a

38.35%

Key Facts

M. Cap

PS

PE

YTD

478.2M

9.7

n/a

38.35%

10MA

20MA

50MA

200MA

$EDIT